Literature DB >> 24889403

Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey.

Philip G Conaghan1, Mark Porcheret, Sarah R Kingsbury, Anne Gammon, Ashok Soni, Michael Hurley, Margaret P Rayman, Julie Barlow, Richard G Hull, Jo Cumming, Kate Llewelyn, Federico Moscogiuri, Jane Lyons, Fraser Birrell.   

Abstract

Osteoarthritis (OA) is the fastest growing cause of disability worldwide. The aim of this study was to understand the impact of OA on individuals and to explore current treatment strategies. An online UK-wide survey of people with self-reported OA was conducted, composed of 52 questions exploring the impact of OA, diagnosis and treatment, the role of health professionals and self-management. Four thousand forty-three people were invited with 2,001 respondents (49 % response, 56 % women; mean age 65 years). Fifty-two percent reported that OA had a large impact on their lives. Fifteen percent of respondents had taken early retirement on average 7.8 years earlier than planned. In consultations with general practitioners, only half reported a discussion on pain; fewer reported discussing their fears (21 %) or management goals (15 %). Nearly half (48 %) reported not seeking medical help until pain was frequently unbearable. Oral analgesics (62 %), topical therapies (47 %), physiotherapy (38 %) and steroid injections (28 %) were commonly used. The majority (71 %) reported varying degrees of persistent pain despite taking all prescribed medication. Although 64 % knew that increasing exercise was important, only 36 % acted on this knowledge; 87 % who increased exercise found it beneficial. Over half had future concerns related to mobility (60 %), maintaining independence (52 %) and coping with everyday activities (51 %). OA had significant individual economic impact especially on employment. Current treatment strategies still leave most people in pain with significant fears for the future. There is considerable opportunity to improve the holistic nature of OA consultations especially in provision of information and promotion of self-management strategies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24889403     DOI: 10.1007/s10067-014-2692-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Care and management of osteoarthritis in adults: summary of NICE guidance.

Authors:  Philip G Conaghan; John Dickson; Robert L Grant
Journal:  BMJ       Date:  2008-03-01

2.  Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases.

Authors:  Kelvin Jordan; Alexandra M Clarke; Deborah P M Symmons; Douglas Fleming; Mark Porcheret; Umesh T Kadam; Peter Croft
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

3.  Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries.

Authors:  Sarah R Kingsbury; Hillary J Gross; Gina Isherwood; Philip G Conaghan
Journal:  Rheumatology (Oxford)       Date:  2014-01-30       Impact factor: 7.580

4.  Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.

Authors:  S E Gabriel; C S Crowson; M E Campion; W M O'Fallon
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

5.  Economic burden of knee and hip osteoarthritis in Spain.

Authors:  Estibaliz Loza; Juan Miguel Lopez-Gomez; Lydia Abasolo; Jesús Maese; Loreto Carmona; Enrique Batlle-Gualda
Journal:  Arthritis Rheum       Date:  2009-02-15

6.  Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force.

Authors:  Monique A M Gignac; Xingshan Cao; Diane Lacaille; Aslam H Anis; Elizabeth M Badley
Journal:  Arthritis Rheum       Date:  2008-12-15

7.  Musculoskeletal disorders as determinants of disability in Finns aged 30 years or more.

Authors:  M Mäkelä; M Heliövaara; K Sievers; P Knekt; J Maatela; A Aromaa
Journal:  J Clin Epidemiol       Date:  1993-06       Impact factor: 6.437

8.  The impact of musculoskeletal hand problems in older adults: findings from the North Staffordshire Osteoarthritis Project (NorStOP).

Authors:  K Dziedzic; E Thomas; S Hill; R Wilkie; G Peat; P R Croft
Journal:  Rheumatology (Oxford)       Date:  2007-02-28       Impact factor: 7.580

9.  The illness perceptions associated with health and behavioural outcomes in people with musculoskeletal hand problems: findings from the North Staffordshire Osteoarthritis Project (NorStOP).

Authors:  S Hill; K Dziedzic; E Thomas; S R Baker; P Croft
Journal:  Rheumatology (Oxford)       Date:  2007-02-17       Impact factor: 7.580

10.  Knee pain and osteoarthritis in the general population: what influences patients to consult?

Authors:  John Bedson; Sara Mottram; Elaine Thomas; George Peat
Journal:  Fam Pract       Date:  2007-08-04       Impact factor: 2.267

View more
  23 in total

Review 1.  Particle-based technologies for osteoarthritis detection and therapy.

Authors:  Taylor E Kavanaugh; Thomas A Werfel; Hongsik Cho; Karen A Hasty; Craig L Duvall
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

2.  [Arthrosis: a scientometric analysis].

Authors:  D Ohlendorf; S Mayer; D Klingelhöfer; M Schwarzer; D A Groneberg
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

3.  The role of thermal balneotherapy in the treatment of obese patient with knee osteoarthritis.

Authors:  Stefano Masiero; Filippo Vittadini; Costanza Ferroni; Anna Bosco; Roberto Serra; Anna Chiara Frigo; Antonio Frizziero
Journal:  Int J Biometeorol       Date:  2017-09-22       Impact factor: 3.787

4.  Demographic and Clinical Factors Associated With Nonsurgical Osteoarthritis Treatment Among Patients in Outpatient Clinics.

Authors:  Lauren M Abbate; Amy S Jeffreys; Cynthia J Coffman; Todd A Schwartz; Liubov Arbeeva; Leigh F Callahan; Nicole A Negbenebor; Wendy M Kohrt; Robert S Schwartz; Ernest Vina; Kelli D Allen
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-05       Impact factor: 4.794

5.  Fully automatic knee osteoarthritis severity grading using deep neural networks with a novel ordinal loss.

Authors:  Pingjun Chen; Linlin Gao; Xiaoshuang Shi; Kyle Allen; Lin Yang
Journal:  Comput Med Imaging Graph       Date:  2019-06-13       Impact factor: 7.422

6.  Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.

Authors:  Sarah R Kingsbury; Puvan Tharmanathan; Nigel K Arden; Michael Batley; Fraser Birrell; Kim Cocks; Michael Doherty; Chris J Edwards; Toby Garrood; Andrew J Grainger; Michael Green; Catherine Hewitt; Rod Hughes; Robert Moots; Terence W O'Neill; Edward Roddy; David L Scott; Fiona E Watt; David J Torgerson; Philip G Conaghan
Journal:  Trials       Date:  2015-03-04       Impact factor: 2.279

7.  Editorial: One Step at a Time: Advances in Osteoarthritis.

Authors:  Ali Mobasheri; Troy N Trumble; Christopher R Byron
Journal:  Front Vet Sci       Date:  2021-07-16

8.  The clinical characteristics of older people with chronic multiple-site joint pains and their utilisation of therapeutic interventions: data from a prospective cohort study.

Authors:  Rafi Raja; Bright Dube; Elizabeth M A Hensor; Sarah F Hogg; Philip G Conaghan; Sarah R Kingsbury
Journal:  BMC Musculoskelet Disord       Date:  2016-04-30       Impact factor: 2.362

9.  Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain.

Authors:  Philip G Conaghan; Michael Serpell; Paula McSkimming; Rod Junor; Sara Dickerson
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

10.  Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severity.

Authors:  J K Sullivan; J Huizinga; R R Edwards; D J Hunter; T Neogi; E Yelin; J N Katz; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2020-11-07       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.